Statescope: an integrative deconvolution framework for discovering cell states in tumors

2026-07-06 · Source: Machine learning : nature.com subject feeds · Field: Science & Research — Life Sciences & Biology, Health & Medical Research, Mathematics & Computational Sciences · Depth: Expert, short

Summary

Statescope is a novel Bayesian framework designed for the integrative deconvolution of cell states in tumors from bulk RNA-seq data. It addresses the challenge of heterogeneous malignant cells by incorporating DNA-derived malignant cell purity and explicitly modeling inter-sample variation. Benchmarking demonstrates Statescope's superior performance over existing methods in both cell fraction and state estimation, notably identifying cell states entirely absent from single-cell references. In real-world applications, Statescope successfully recapitulates known cell states, including multiple neutrophil states in lung cancer, which are often overlooked by single-cell techniques. Furthermore, in the POPLAR/OAK clinical trials, Statescope identified a combinatorial signature of effector CD8+ T cells and conventional dendritic cell states that predicts a significant survival benefit from immunotherapy. This framework transforms deconvolution into a versatile discovery platform for deeper biological and clinical insights from widely available bulk multi-omics data.

Key takeaway

For research scientists analyzing tumor microenvironment data or seeking predictive biomarkers, Statescope offers a robust approach to overcome limitations of traditional deconvolution. You should consider integrating this Bayesian framework to accurately identify cell states, especially those missed by single-cell methods, and to discover combinatorial signatures from bulk multi-omics data that predict patient survival benefits from immunotherapies. This could refine your understanding of tumor biology and improve patient stratification.

Key insights

Statescope is a Bayesian framework that accurately deconvolutes tumor cell states from bulk RNA-seq by accounting for malignant cell purity and inter-sample variation.

Principles

• Tumor heterogeneity in bulk RNA-seq can be overcome by integrating DNA-derived purity.
• Modeling inter-sample variation improves cell state identification accuracy.
• Deconvolution methods can reveal cell states absent from single-cell references.

Method

Statescope employs a Bayesian framework to incorporate DNA-derived malignant cell purity and explicitly model inter-sample variation, enabling accurate cell fraction and state estimation from bulk tumor RNA-seq.

In practice

• Identify novel or missed cell states in tumors from bulk RNA-seq data.
• Discover combinatorial cell signatures predictive of immunotherapy survival benefits.

Topics

• Cell State Deconvolution
• Tumor Microenvironment
• RNA-seq
• Bayesian Framework
• Immunotherapy Response
• Biomarker Discovery

Best for: AI Scientist, Research Scientist, Data Scientist

Related on AIssential

• Querying Counterfactuals on Tissue Graphs with Supervised Disentanglement — Cellina disentangles intrinsic cell state from spatial context to predict counterfactual cell expression on tissue graphs.
• Improved tumor-only variant calling and mutation burden estimation with VarNet-T — VarNet-T improves tumor-only somatic variant calling and TMB estimation using weakly supervised deep learning.
• Bayesian In Vivo Tracking of Synapses using Joint Poisson Deconvolution and Diffeomorphic Registration — A Bayesian framework enables robust, simultaneous synapse tracking, denoising, and registration in noisy in vivo microscopy data.
• Prototype-driven fusion of pathology and spatial transcriptomics for interpretable survival prediction — PathoSpatial fuses WSI and ST data via prototype learning for interpretable, spatially-informed survival prediction.
• Non-invasive profiling of the tumour microenvironment with spatial ecotypes — A new machine learning framework enables non-invasive profiling of tumor microenvironment spatial ecotypes from liquid biopsies, predicting immunotherapy response.
• Predicting and interpreting cell-type-specific drug responses in the small-data regime using inductive priors — PrePR-CT uses graph-based deep learning with cell-type-specific co-expression networks to predict drug responses in data-limited settings.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Machine learning : nature.com subject feeds.